Cargando…
Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanoma
MYC's key role in oncogenesis and tumor progression has long been established for most human cancers. In melanoma, its deregulated activity by amplification of 8q24 chromosome or by upstream signaling coming from activating mutations in the RAS/RAF/MAPK pathway—the most predominantly mutated pa...
Autores principales: | Zacarías-Fluck, Mariano F., Massó-Vallés, Daniel, Giuntini, Fabio, González-Larreategui, Íñigo, Kaur, Jastrinjan, Casacuberta-Serra, Sílvia, Jauset, Toni, Martínez-Martín, Sandra, Martín-Fernández, Génesis, Serrano del Pozo, Erika, Foradada, Laia, Grueso, Judit, Nonell, Lara, Beaulieu, Marie-Eve, Whitfield, Jonathan R., Soucek, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153459/ https://www.ncbi.nlm.nih.gov/pubmed/37024284 http://dx.doi.org/10.1101/gad.350078.122 |
Ejemplares similares
-
The Wnt signaling receptor Fzd9 is essential for Myc-driven tumorigenesis in pancreatic islets
por: Zacarías-Fluck, Mariano F, et al.
Publicado: (2021) -
MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and Seeding
por: Massó-Vallés, Daniel, et al.
Publicado: (2022) -
Pharmacokinetic Analysis of Omomyc Shows Lasting Structural Integrity and Long Terminal Half-Life in Tumor Tissue
por: Beaulieu, Marie-Eve, et al.
Publicado: (2023) -
BET inhibition is an effective approach against KRAS-driven PDAC and NSCLC
por: Jauset, Toni, et al.
Publicado: (2018) -
Ibrutinib repurposing: from B-cell malignancies to solid tumors
por: Massó-Vallés, Daniel, et al.
Publicado: (2016)